Literature DB >> 26827791

Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patients.

Jonel Trebicka1, Matthias von Heydebrand2, Jennifer Lehmann2, Flemming Tofteng3, Troels Busk4, Helle Lone Jensen5, Johan Rohde6, Thomas Reiberger7, Christian Mortensen8, Robert Schierwagen2, Sabine Klein2, Søren Møller4, Flemming Bendtsen3, Aleksander Krag9.   

Abstract

BACKGROUND & AIMS: Non-selective beta-blockers (NSBB) are first choice for prevention of variceal bleeding. But possible deleterious effects in refractory ascites and frequent non-response are clinical drawbacks. Since levels of vasoactive proteins in antrum mucosa reflect vascular dysfunction in cirrhosis, these expression levels might also reflect hemodynamic response to NSBB.
METHODS: Biopsies from the gastric and duodenal mucosa of 25 patients with cirrhosis were collected and the hepatic venous pressure gradient (HVPG) was measured before and after an acute propranolol challenge. Transcription and protein expression of Ras homolog family member A (RhoA), Rho-kinase (ROCK)2, beta-arrestin2 (βArr2), endothelial nitric oxide synthase (eNOS) and the phosphorylation of downstream effectors VASP and moesin were analyzed using PCR and Western blot. Further 21 patients on NSBB were evaluated on their follow up for events of variceal bleeding defined as non-response.
RESULTS: Ten patients showed HVPG <10mmHg, further seven patients showed significant hemodynamic response to NSBB, whereas eight patients were non-responders. The mucosal transcription of vasoactive proteins was higher in antrum mucosa compared to corpus and duodenum. The transcriptional levels of vasoactive proteins were higher in patients with HVPG >10mmHg and HVPG >16mmHg. Interestingly, mRNA levels of RhoA and ROCK2 were lower in patients with large varices at endoscopy. Moreover, RhoA and ROCK2 transcription correlated with the decrease of HVPG after acute NSBB challenge. Finally, acute and long-term non-responders showed lower expression of βArr2 in antrum mucosa.
CONCLUSION: This study shows for the first time that the expression of βArr2 in antrum mucosa biopsies might reflect the hemodynamic response to NSBB and their long-term protective effect. This finding might offer an easy approach at upper endoscopy to facilitate the decision to treat with NSBB if varices are present.
Copyright © 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Beta-blocker; Gastric mucosa; Portal hypertension; Vasoactive proteins

Mesh:

Substances:

Year:  2016        PMID: 26827791     DOI: 10.1016/j.jhep.2016.01.022

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  5 in total

1.  Portal hypertensive gastropathy is associated with iron deficiency anemia.

Authors:  Benedikt Simbrunner; Andrea Beer; Katharina Wöran; Fabian Schmitz; Christian Primas; Marlene Wewalka; Matthias Pinter; Werner Dolak; Bernhard Scheiner; Andreas Puespoek; Michael Trauner; Georg Oberhuber; Mattias Mandorfer; Thomas Reiberger
Journal:  Wien Klin Wochenschr       Date:  2020-01-07       Impact factor: 1.704

2.  The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid.

Authors:  Jinshan Wang; Wentao Jiang
Journal:  Med Sci Monit       Date:  2020-02-06

3.  Liver stiffness assessment as an alternative to hepatic venous pressure gradient for predicting rebleed after acute variceal bleed: A proof-of-concept study.

Authors:  Samagra Agarwal; Sanchit Sharma; Abhinav Anand; Deepak Gunjan; Anoop Saraya
Journal:  JGH Open       Date:  2020-11-09

4.  β-arrestin-2 predicts the clinical response to β-blockers in cirrhotic portal hypertension patients: A prospective study.

Authors:  Sameh A Lashen; Mohammed M Shamseya; Marwa A Madkour; Radwa M Abdel Salam; Sanaa S Mostafa
Journal:  World J Hepatol       Date:  2022-02-27

5.  β-Arrestin2 is increased in liver fibrosis in humans and rodents.

Authors:  Robert Schierwagen; Peter Dietrich; Sabine Klein; Frank Erhard Uschner; Cristina Ortiz; Olaf Tyc; Sandra Torres; Claus Hellerbrand; Tilman Sauerbruch; Jonel Trebicka
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-03       Impact factor: 12.779

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.